![](/img/cover-not-exists.png)
PMH40 COST-UTILITY ANALYSIS (CUA) OF SERTINDOLE IN THE TREATMENT OF SCHIZOPHRENIA IN POLAND IN GENERAL POPULATION OF SCHIZOPHRENIC PATIENTS AND POPULATION OF PATIENTS INTOLERANT TO AT LEAST ONE OTHER ANTIPSYCHOTIC AGENT: A FIVE-YEAR MARKOV MODEL
Walczak, J, Stelmachowski, J, Obrzut, G, Nogas, GVolume:
13
Language:
english
Journal:
Value in Health
DOI:
10.1016/S1098-3015(11)72917-5
Date:
November, 2010
File:
PDF, 70 KB
english, 2010